hrp0089p2-p148 | Fat, Metabolism and Obesity P2 | ESPE2018

Evaluation of Hydration Status of Obese Children – A Pilot Study

Akif Celik , Nurcan Cebeci Ayse

Background: Although adequate hydration is recommended for healthy nutrition, the link between less water consumption and obesity is not exactly known. It was demonstrated that less hydrated adults had a higher body mass index (BMI). Data in children are rather limited. Our aim was to compare the hydration status between obese and non-obese children.Subjects and methods: Children aged between 7 and 18 years who had a BMI over 2 standard deviation score (...

hrp0082p3-d1-622 | Adrenals & HP Axis | ESPE2014

Body Composition Analysis in Girls With Premature Adrenarche

Nurcan Cebeci Ayse , Tas Aysegul

Background: Idiopathic premature adrenarche (PA) in girls refers to the presence of androgenic signs before the age of 8 years in the absence of thelarche. Increased adrenal androgens lead to changes in body composition and transient growth acceleration without effecting final height. Although the association between PA and some components of the metabolic syndrome is well known, total body fat and body composition analysis are not widely studied.Subject...

hrp0095p1-24 | Bone, Growth Plate and Mineral Metabolism | ESPE2022

SIADH as presenting feature of foramen magnum stenosis in a 2-month-old infant with achondroplasia (ACH): case report and discussion on management of infants with ACH in order to reduce the risk of serious complications

Nurcan Cebeci Ayse , Hebert Steven , Reutter Heiko , Wölfle Joachim

Background and Aim: Achondroplasia is the most common skeletal dysplasia and is associated with serious complications such as foramen magnum stenosis (FMS). Current guidelines in Germany recommend polysomnography at 2-3 months and cranial imaging at 6-9 months of life in achondroplasia, whereas American Academy of Pediatrics recommends to evaluate every infant with achondroplasia for cranio-cervical junction risks via neurologic examination, polysomnography an...

hrp0098p2-5 | Adrenals and HPA Axis | ESPE2024

Pharmacological therapy of adrenal hypercortisolism in a boy with suspected isolated micronodular adrenal hyperplasia (iMAD) due to a mutation in the PDE11A gene

Marx Michaela , F. Gaßmann Katja , Tzschoppe Anja , Nurcan Cebeci Ayse , Woelfle Joachim

Background: iMAD is a very rare cause of ACTH-independent Cushing´s syndrome in young children. Bilateral adrenalectomy is a definitive treatment, but poses young children at a high risk due to life-long adrenal insufficiency. Therefore, pharmacological treatment with metyrapone seems an alternative bridging option for a limited period of time.Case report: A 3 6/12 year old boy presented with a history of rapid wei...

hrp0097p1-198 | Thyroid | ESPE2023

Graves’ disease in children with Down syndrome

Nurcan Cebeci Ayse , Schempp Vera , Reinauer Christina , Gohlke Bettina , Marx Michaela , Dörr Helmuth-Günther , Woelfle Joachim

Introduction: Thyroid abnormalities such as subclinical or overt hypothyroidism are common in children with Down syndrome (DS) with ranges from 4% to 19.5%, whereas Graves´ disease (GD) is extremely rare (ranges 0.6%-0.9 %).Aims: To evaluate clinical features, course, and treatment of GD in children with DS.Patients and Methods: Among 161 children with GD, diagnosed between 1...

hrp0098p3-254 | Thyroid | ESPE2024

Chief complaints at initial presentation of children with Graves’ disease

Nurcan Cebeci Ayse , Schempp Vera , Förtsch Katharina , Gohlke Bettina , Marx Michaela , Dörr Helmuth-Günther , Woelfle Joachim

Introduction: Children with Graves' disease (GD) show a set of characteristic clinical symptoms but data describing the chief complaints that led to the initial presentation are rare.Aims: To evaluate the spectrum of complaints of children with GD at initial presentation.Patients and Methods: We performed a retrospective review of the medical records of 148 children with bioch...

hrp0097p1-388 | Thyroid | ESPE2023

Neutropenia in paediatric Graves disease patients occurs more often under Carbimazole than Methimazole

Schempp Vera , Nurcan Cebeci Ayse , Reinauer Christina , Woelfle Joachim , Dörr Helmuth-Günther , Roosen Marie-Thérèse , Gohlke Jonas , Gohlke Bettina

Introduction: Neutropenia is known as a rare adverse event of anti-thyroid drug treatment (ATD) but has also been reported as pre-treatment neutropenia in Graves’ disease (GD). Studies on paediatric patients are rare. To the best of our knowledge, there are no data comparing the effects of methimazole (MMI) and carbimazole (CBZ) treatment in children on the absolute neutrophil count (ANC).Methods: We analyzed retro...